-
公开(公告)号:US20230050022A1
公开(公告)日:2023-02-16
申请号:US17813021
申请日:2022-07-15
Applicant: University of Washington , Seattle Children's Hospital d/b/a Seattle Children's Research Institute
Inventor: Suzie Hwang Pun , Nataly Kacherovsky , Emmeline Cheng , Ian Cardle , Michael Jensen
IPC: C12N5/00 , C12N15/115 , A61K47/54 , A61K35/17
Abstract: Described herein are aptamers that bind to the transferrin receptor (e.g., CD71) and can be used, in part, for depleting transferrin receptor-expressing cells from a population of therapeutic cells. These aptamer compositions can be used in methods for isolating and/or enriching cells expressing CD71 or depleting cell populations of cells expressing CD71, including for example, tumor cells. Further provided are methods of using the aptamers or cell populations generated using them in the methods disclosed herein for therapies and/or drug delivery.
-
公开(公告)号:US20230046027A1
公开(公告)日:2023-02-16
申请号:US17791676
申请日:2021-01-12
Applicant: University of Washington
Inventor: Bruce J. Godfrey , Mari-Karoliina Henriikka Winkler , David Stahl
Abstract: The present disclosure describes a microorganism support structure, including a gas-permeable layer comprising two opposing surfaces; a microorganism adhesive coats at least one surface of the gas-permeable layer; and a microorganism disposed on the microorganism adhesive-coated surface of the layer. The microorganism adhesive enhances the adhesion of the microorganism on the layer compared to a gas-permeable layer that does not have the microorganism adhesive.
-
113.
公开(公告)号:US11566287B2
公开(公告)日:2023-01-31
申请号:US17392180
申请日:2021-08-02
Inventor: Jesse Salk , Lawrence A. Loeb , Michael Schmitt
IPC: C12Q1/68 , C12Q1/6876 , C12Q1/6806 , C12Q1/6869
Abstract: Next Generation DNA sequencing promises to revolutionize clinical medicine and basic research. However, while this technology has the capacity to generate hundreds of billions of nucleotides of DNA sequence in a single experiment, the error rate of approximately 1% results in hundreds of millions of sequencing mistakes. These scattered errors can be tolerated in some applications but become extremely problematic when “deep sequencing” genetically heterogeneous mixtures, such as tumors or mixed microbial populations. To overcome limitations in sequencing accuracy, a method Duplex Consensus Sequencing (DCS) is provided. This approach greatly reduces errors by independently tagging and sequencing each of the two strands of a DNA duplex. As the two strands are complementary, true mutations are found at the same position in both strands. In contrast, PCR or sequencing errors will result in errors in only one strand. This method uniquely capitalizes on the redundant information stored in double-stranded DNA, thus overcoming technical limitations of prior methods utilizing data from only one of the two strands.
-
114.
公开(公告)号:US11549144B2
公开(公告)日:2023-01-10
申请号:US17392185
申请日:2021-08-02
Inventor: Jesse Salk , Lawrence A. Loeb , Michael Schmitt
IPC: C12Q1/6876 , C12Q1/6806 , C12Q1/6869
Abstract: Next Generation DNA sequencing promises to revolutionize clinical medicine and basic research. However, while this technology has the capacity to generate hundreds of billions of nucleotides of DNA sequence in a single experiment, the error rate of approximately 1% results in hundreds of millions of sequencing mistakes. These scattered errors can be tolerated in some applications but become extremely problematic when “deep sequencing” genetically heterogeneous mixtures, such as tumors or mixed microbial populations. To overcome limitations in sequencing accuracy, a method Duplex Consensus Sequencing (DCS) is provided. This approach greatly reduces errors by independently tagging and sequencing each of the two strands of a DNA duplex. As the two strands are complementary, true mutations are found at the same position in both strands. In contrast, PCR or sequencing errors will result in errors in only one strand. This method uniquely capitalizes on the redundant information stored in double-stranded DNA, thus overcoming technical limitations of prior methods utilizing data from only one of the two strands.
-
115.
公开(公告)号:US20220415444A1
公开(公告)日:2022-12-29
申请号:US17850739
申请日:2022-06-27
Applicant: University of Washington
Inventor: Ling-Hong Hung , Ka Yee Yeung-Rhee
IPC: G16B30/10
Abstract: In some embodiments, a computer-implemented method of comparing strings representing nucleotide sequences is provided. A plurality of values representing Hamming distances between first strings and second strings are determined by converting value characters in the first string and the second string to a one hot encoding and converting any unknown characters in the first string and the second string to a zero value to create a first bit representation and a second bit representation; comparing the first bit representation and the second bit representation using a bitwise XOR operation to obtain a bitwise XOR result; counting a number of bits in the bitwise XOR result and multiplying the bitwise XOR result by two to obtain a bitcount result; and adjusting the bitcount result based on unknown characters in at least one of the first string and the second string to obtain the value representing the Hamming distance.
-
公开(公告)号:US20220411046A1
公开(公告)日:2022-12-29
申请号:US17756225
申请日:2020-11-19
Applicant: UNIVERSITY OF WASHINGTON
Inventor: Giovanni NINO , Lucas J. WEBER , Tobias WITTIG , Robert E. BREIDENTHAL
Abstract: Apparatuses and methods for controlling fluid flow over surfaces, e.g. wings, are disclosed. A system can include a surface influenced by a fluid flow moving across the surface, a vortex generator disposed proximate to the surface, the vortex generator for altering a vortex pattern within the fluid flow moving across the surface, and a controller for activating the vortex generator to alter the vortex pattern within the fluid flow moving across the surface. The vortex generator can comprise one or more fluid injectors each for injecting a fluid jet into the fluid flow driven by air pressure. The fluid injectors can be disposed along a leading edge of a strake where the strake is disposed on an engine nacelle and the surface comprises an aircraft wing surface. Activation can occur under open or closed loop control with sensors.
-
公开(公告)号:US20220395838A1
公开(公告)日:2022-12-15
申请号:US17838807
申请日:2022-06-13
Applicant: University of Washington
Inventor: Paul Yager , Steven Bennett , Erin K. Heiniger , Sujatha Kumar , Kamal Girish Shah
IPC: B01L7/00 , B01L3/00 , C12Q1/6806
Abstract: Fluidic devices, systems, and methods for analyzing an analyte are described. In an embodiment, the fluidic devices include a housing defining a lysis chamber shaped to receive a biological sample; a lysis buffer storage chamber disposed within the housing and carrying a lysis buffer configured to lyse cells of the biological sample; a cap configured to cooperatively couple to the housing; a compressor configured to compress the lysis buffer storage chamber and expel the lysis buffer from the lysis buffer storage chamber and into the lysis chamber when the cap is uncoupled from the housing; and a porous membrane in selective fluidic communication with the lysis chamber.
-
公开(公告)号:US20220389310A1
公开(公告)日:2022-12-08
申请号:US17762599
申请日:2020-09-24
Applicant: University of Washington
Inventor: Yunping Huang , Christine Keiko Luscombe, III
IPC: C09K11/06 , C07D519/00 , C07D473/12 , H01L51/00
Abstract: The present disclosure features a luminescent molecule, including a luminophore (e.g., a fluorescent dye); and a moiety including a heteroaryl core covalently and directly bonded to the luminophore. The luminescent molecule has an increased photoluminescence quantum yield relative to an analogous luminophore without a covalently bonded moiety including the heteroaryl core.
-
公开(公告)号:US20220380367A1
公开(公告)日:2022-12-01
申请号:US17813318
申请日:2022-07-18
Applicant: UNIVERSITY OF WASHINGTON , THE UNIVERSITY OF MONTANA
Inventor: Nephi STELLA , Philippe DIAZ
IPC: C07D471/04
Abstract: This disclosure relates to compounds that target microtubules, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases. More particularly, this disclosure relates to modified carbazole compounds and pharmaceutical compositions thereof, methods of targeting microtubules with these compounds, and methods of treating diseases affected by microtubule disruption.
-
公开(公告)号:US11512160B2
公开(公告)日:2022-11-29
申请号:US15578633
申请日:2016-06-02
Applicant: University of Washington
Inventor: Shaoyi Jiang , Tao Bai , Jean-René Ella-Menye , Hsiang-Chieh Hung , Priyesh Jain , Andrew Sinclair , Harihara Subramanian Sundaram , Yang Li , Peng Zhang
IPC: C08F220/34 , C08F220/36 , C08F220/48 , C08F220/44 , C08F220/50 , C08F220/42 , C08F220/60 , A61K47/58 , A61K47/59 , C07F9/09 , C07C229/16 , C07C265/04 , C07C229/12 , C07C255/23 , C07C237/22 , C07C253/30 , C07C255/26 , C09D5/16 , C09D7/65 , C08G18/38 , C08G18/78 , C08G61/08 , C08G61/12 , C08G63/685 , C08G69/26 , C08G69/42 , C08G73/02 , C08G73/06 , C08L35/02 , C08L65/00 , C08L67/02 , C08L75/04 , C08L77/06 , C08L79/02 , C08L79/04 , C09D135/02 , C09D165/00 , C09D167/02 , C09D175/04 , C09D177/06 , C09D179/02 , C09D179/04 , C08G61/06 , C08G63/00 , C08F222/32
Abstract: Free-standing non-fouling polymers and polymeric compositions, monomers and macromonomers for making the polymers and polymeric compositions, objects made from the polymers and polymeric compositions, and methods for making and using the polymers and polymeric compositions.
-
-
-
-
-
-
-
-
-